dinitrofluorobenzene has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harasym, TO; Hope, MJ; Klimuk, SK; Semple, SC | 1 |
| Berd, D; Cohn, H; Maguire, HC; Mastrangelo, MJ; Sato, T | 1 |
2 other study(ies) available for dinitrofluorobenzene and Lung Neoplasms
| Article | Year |
|---|---|
Lipid-based formulations of antisense oligonucleotides for systemic delivery applications.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Capsules; Culture Media; Detergents; Dinitrofluorobenzene; Drug Carriers; Humans; Inflammation; Liposomes; Lung Neoplasms; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Oligodeoxyribonucleotides, Antisense; Phospholipids | 2000 |
Treatment of metastatic melanoma with autologous, hapten-modified melanoma vaccine: regression of pulmonary metastases.
Topics: Adult; Aged; Aged, 80 and over; Cancer Vaccines; Dinitrofluorobenzene; Disease-Free Survival; Female; Haptens; Humans; Hypersensitivity, Delayed; Immunotherapy; Inflammation; Lung Neoplasms; Male; Melanoma; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Skin Neoplasms; Time Factors; Treatment Outcome; Vaccines | 2001 |